Complete Guide to Your Laboratory Test: What It Is, Why It Is Done, and How to Understand Your Results
This test measures the amount of acenocoumarol, an anticoagulant (blood thinner) medication, in your urine.
{"Acenocoumarol is a blood-thinning medication used to prevent blood clots","This test checks how much of the drug is in your urine","It helps doctors monitor if you're taking the right dose","The test is simple and uses a urine sample","Results help ensure your treatment is safe and effective"}
Key facts at a glance
- LOINC
- 78775-4
- Short code
- ACEN-UR
- Synonyms
- Acenocoumarol Ur-mCnc
- Category
- chemistry
- Sample
- urine
- Container
- Clean, sterile, labeled urine container (plastic or glass) without preservatives
- Units
- N/A
- Ref low
- 0.1
- Ref high
- 2
- Critical range
- 0.05 N/A – 5 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 18 years
- Method
- Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) or High-Performance Liquid Chromatography (HPLC) with UV detection
- CPT
- 80375
- SNOMED
- 385058005
- Specimen volume
- Minimum 10 mL, preferred 20-50 mL
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C): 30 days. Protect from light.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 24–72 hours
- Order
- routine
This test is a laboratory procedure that analyzes a sample from your body, such as blood, urine, or tissue, to give your healthcare team important information about how your body is working and whether any medical condition may need attention.
The Urine Acenocoumarol test measures the concentration of acenocoumarol in your urine. Acenocoumarol is an anticoagulant medication, commonly known as a blood thinner. It belongs to a class of drugs called vitamin K antagonists, which help prevent the formation of dangerous blood clots in your blood vessels.
Your doctor may order this test to help diagnose a medical condition, screen for disease before symptoms appear, check how well an organ is functioning, or monitor the effectiveness of a treatment you are already receiving.
This test is performed to monitor acenocoumarol levels in patients who are taking this medication for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation, or after certain surgeries like heart valve replacement. Regular monitoring helps ensure the drug is working effectively and that the dose is appropriate for you.
The test is usually performed by a trained healthcare professional who collects a small sample, most often by drawing blood from a vein in your arm or by asking you to provide a urine specimen. The sample is then sent to a laboratory, and the collection itself typically takes only a few minutes.
A urine sample is collected in a sterile container. You may be asked to provide a first-morning sample or a random urine sample, depending on your doctor's instructions. The sample is then sent to a laboratory where it is analyzed using specialized equipment to measure the acenocoumarol concentration.
This test is considered very safe. If your blood is drawn, you may feel brief discomfort, notice minor bruising, or have slight soreness at the needle site, and some people feel lightheaded for a moment. Serious complications, such as infection or excessive bleeding, are rare.
This test involves collecting a urine sample, which is generally safe and has no significant risks. The procedure is non-invasive and does not cause any pain or discomfort.
Your results are compared with established reference ranges to show whether your values fall within normal limits. Results outside the expected range do not always mean you have a serious condition, so your healthcare provider will review them with you, explain what they mean in context, and recommend any follow-up testing or treatment if needed.
Your test results will show the amount of acenocoumarol in your urine. Your doctor will interpret these results along with other tests (such as INR - International Normalized Ratio) to determine if your current medication dose is appropriate. Too little medication may not prevent clots effectively, while too much may increase your risk of bleeding.
Reference range
Therapeutic monitoring: 0.1-2.0 mcg/mL (patient-specific based on INR target); Non-detectable levels indicate non-compliance or subtherapeutic dosingN/A
Collect clean-catch midstream urine sample. Inform laboratory of current acenocoumarol dosage and timing of last dose. No fasting required. Avoid contamination with toilet paper or fecal material.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The Urine Acenocoumarol test is clinically significant for therapeutic drug monitoring. It helps healthcare providers ensure that patients maintain therapeutic levels of the anticoagulant to prevent thromboembolic events while minimizing the risk of bleeding complications. This test is particularly useful in patients who have difficulty maintaining stable INR levels or when there is concern about medication adherence.
Frequently asked questions
Do I need to fast before this test?
Can I take my acenocoumarol medication before the test?
How often do I need this test?
What should I tell my doctor before the test?
What happens if my acenocoumarol level is too high or too low?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy